RAC 0.57% $1.75 race oncology ltd

Ann: First Patient Dosed in Phase 1b/2 AML Trial, page-244

  1. 162 Posts.
    lightbulb Created with Sketch. 574
    Ann: Zantrene AML trial in Israel advances to Phase 2
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.